Biolase, Inc. (BIOLQ) vs Bluejay Diagnostics, Inc. (BJDX)
- Biolase, Inc. BIOLQ 0.00 NaN
- Bluejay Diagnostics, Inc. BJDX 0.75 −3.85%
Biolase, Inc. and Bluejay Diagnostics, Inc. are both Medical Devices companies. Bluejay Diagnostics, Inc. is the larger, with a market value of $3.5M against $2.3M — 1.5× the size. Biolase, Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 0.9×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −71.8%) and the higher return on invested capital (0.00% vs −109.5%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 8 and Biolase, Inc. on 5.
Valuation
Profitability
| Metric | BIOLQ | BJDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 0.00% | 56.01% |
| Operating margin | (29.37%) | 0.00% | (15.03%) |
| Net margin | (71.75%) | 0.00% | (20.40%) |
| Free cash flow margin | (28.55%) | 0.00% | (7.24%) |
| Return on equity | 1,349.30% | (98.89%) | (15.32%) |
| Return on assets | (100.09%) | (81.07%) | (19.72%) |
| Return on invested capital | (109.48%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack